CN102764394B - 治疗生殖性疾病的化毒和菌中药组合物及其制备方法 - Google Patents
治疗生殖性疾病的化毒和菌中药组合物及其制备方法 Download PDFInfo
- Publication number
- CN102764394B CN102764394B CN201210251606.3A CN201210251606A CN102764394B CN 102764394 B CN102764394 B CN 102764394B CN 201210251606 A CN201210251606 A CN 201210251606A CN 102764394 B CN102764394 B CN 102764394B
- Authority
- CN
- China
- Prior art keywords
- parts
- herba
- chinese medicine
- medicine composition
- fructus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 179
- 239000000203 mixture Substances 0.000 title claims abstract description 63
- 241000894006 Bacteria Species 0.000 title claims abstract description 44
- 238000002360 preparation method Methods 0.000 title claims abstract description 26
- 208000017443 reproductive system disease Diseases 0.000 title abstract description 8
- 239000003053 toxin Substances 0.000 title abstract description 5
- 231100000765 toxin Toxicity 0.000 title abstract description 5
- 230000001131 transforming effect Effects 0.000 title abstract 3
- 238000011282 treatment Methods 0.000 claims abstract description 53
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 32
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 32
- 235000008434 ginseng Nutrition 0.000 claims abstract description 32
- 238000000034 method Methods 0.000 claims abstract description 16
- 241000628997 Flos Species 0.000 claims description 79
- 229940079593 drug Drugs 0.000 claims description 77
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 74
- 201000010099 disease Diseases 0.000 claims description 73
- 231100000614 poison Toxicity 0.000 claims description 55
- 210000000582 semen Anatomy 0.000 claims description 50
- 239000003440 toxic substance Substances 0.000 claims description 48
- 239000000829 suppository Substances 0.000 claims description 36
- 241000208340 Araliaceae Species 0.000 claims description 31
- RSIJVJUOQBWMIM-UHFFFAOYSA-L sodium sulfate decahydrate Chemical group O.O.O.O.O.O.O.O.O.O.[Na+].[Na+].[O-]S([O-])(=O)=O RSIJVJUOQBWMIM-UHFFFAOYSA-L 0.000 claims description 23
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 20
- 241000202755 Areca Species 0.000 claims description 19
- 241000555712 Forsythia Species 0.000 claims description 19
- 235000005903 Dioscorea Nutrition 0.000 claims description 18
- 241000234273 Dioscorea Species 0.000 claims description 18
- 235000000504 Dioscorea villosa Nutrition 0.000 claims description 18
- 241000545442 Radix Species 0.000 claims description 18
- 241000405217 Viola <butterfly> Species 0.000 claims description 18
- 235000004879 dioscorea Nutrition 0.000 claims description 18
- 239000009636 Huang Qi Substances 0.000 claims description 12
- 238000009835 boiling Methods 0.000 claims description 12
- 239000006071 cream Substances 0.000 claims description 12
- 239000006228 supernatant Substances 0.000 claims description 12
- 239000013078 crystal Substances 0.000 claims description 9
- 239000008155 medical solution Substances 0.000 claims description 9
- 239000004744 fabric Substances 0.000 claims description 6
- 239000000706 filtrate Substances 0.000 claims description 6
- 238000001914 filtration Methods 0.000 claims description 6
- 239000002574 poison Substances 0.000 claims description 6
- 239000000843 powder Substances 0.000 claims description 6
- 238000010298 pulverizing process Methods 0.000 claims description 6
- 238000007796 conventional method Methods 0.000 claims description 3
- 238000007654 immersion Methods 0.000 claims description 3
- 238000007789 sealing Methods 0.000 claims description 3
- 238000002791 soaking Methods 0.000 claims description 3
- 230000001954 sterilising effect Effects 0.000 claims description 3
- 238000009423 ventilation Methods 0.000 claims description 3
- 241000245240 Lonicera Species 0.000 claims 3
- 230000000694 effects Effects 0.000 abstract description 88
- 241000893536 Epimedium Species 0.000 abstract description 14
- 235000018905 epimedium Nutrition 0.000 abstract description 14
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract description 4
- 241001061264 Astragalus Species 0.000 abstract description 2
- 235000002566 Capsicum Nutrition 0.000 abstract description 2
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 abstract description 2
- 235000006533 astragalus Nutrition 0.000 abstract description 2
- 230000002829 reductive effect Effects 0.000 abstract description 2
- 210000004233 talus Anatomy 0.000 abstract description 2
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 244000080767 Areca catechu Species 0.000 abstract 1
- 235000006226 Areca catechu Nutrition 0.000 abstract 1
- 244000035851 Chrysanthemum leucanthemum Species 0.000 abstract 1
- 241000892667 Cnidium silaifolium Species 0.000 abstract 1
- 240000000774 Cunila origanoides Species 0.000 abstract 1
- 235000018274 Cunila origanoides Nutrition 0.000 abstract 1
- 244000301850 Cupressus sempervirens Species 0.000 abstract 1
- 235000014866 Dictamnus albus Nutrition 0.000 abstract 1
- 235000002722 Dioscorea batatas Nutrition 0.000 abstract 1
- 235000006536 Dioscorea esculenta Nutrition 0.000 abstract 1
- 240000001811 Dioscorea oppositifolia Species 0.000 abstract 1
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 abstract 1
- 244000281702 Dioscorea villosa Species 0.000 abstract 1
- 241000735527 Eupatorium Species 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 241000207925 Leonurus Species 0.000 abstract 1
- 235000003805 Musa ABB Group Nutrition 0.000 abstract 1
- 240000008790 Musa x paradisiaca Species 0.000 abstract 1
- 240000001659 Oldenlandia diffusa Species 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 241000758706 Piperaceae Species 0.000 abstract 1
- 235000015266 Plantago major Nutrition 0.000 abstract 1
- 241000923606 Schistes Species 0.000 abstract 1
- 235000000485 Smilax china Nutrition 0.000 abstract 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 abstract 1
- 240000001949 Taraxacum officinale Species 0.000 abstract 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 abstract 1
- 229910052891 actinolite Inorganic materials 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 239000010446 mirabilite Substances 0.000 abstract 1
- 239000002994 raw material Substances 0.000 abstract 1
- 239000000454 talc Substances 0.000 abstract 1
- 229910052623 talc Inorganic materials 0.000 abstract 1
- 239000000047 product Substances 0.000 description 62
- 210000003734 kidney Anatomy 0.000 description 24
- 208000002193 Pain Diseases 0.000 description 21
- 230000036407 pain Effects 0.000 description 21
- 210000004185 liver Anatomy 0.000 description 20
- 210000000952 spleen Anatomy 0.000 description 18
- 210000002784 stomach Anatomy 0.000 description 17
- 206010007247 Carbuncle Diseases 0.000 description 15
- 239000008280 blood Substances 0.000 description 15
- 210000004369 blood Anatomy 0.000 description 15
- 235000009508 confectionery Nutrition 0.000 description 13
- 230000006870 function Effects 0.000 description 13
- 208000003251 Pruritus Diseases 0.000 description 11
- 208000004880 Polyuria Diseases 0.000 description 10
- 230000000844 anti-bacterial effect Effects 0.000 description 10
- 230000035619 diuresis Effects 0.000 description 10
- 208000001848 dysentery Diseases 0.000 description 10
- 210000004072 lung Anatomy 0.000 description 10
- 238000005728 strengthening Methods 0.000 description 10
- 230000008961 swelling Effects 0.000 description 10
- 206010042674 Swelling Diseases 0.000 description 9
- -1 XIAOMI SHUAN Chemical compound 0.000 description 9
- 238000002651 drug therapy Methods 0.000 description 9
- 230000035876 healing Effects 0.000 description 9
- 230000027939 micturition Effects 0.000 description 9
- 201000004624 Dermatitis Diseases 0.000 description 8
- 206010017553 Furuncle Diseases 0.000 description 8
- 229930182470 glycoside Natural products 0.000 description 8
- 239000008194 pharmaceutical composition Substances 0.000 description 8
- 230000001737 promoting effect Effects 0.000 description 8
- 206010030113 Oedema Diseases 0.000 description 7
- 208000029082 Pelvic Inflammatory Disease Diseases 0.000 description 7
- 206010047799 Vulvovaginitis trichomonal Diseases 0.000 description 7
- 230000009471 action Effects 0.000 description 7
- 230000003110 anti-inflammatory effect Effects 0.000 description 7
- 201000001881 impotence Diseases 0.000 description 7
- 208000010228 Erectile Dysfunction Diseases 0.000 description 6
- 206010062717 Increased upper airway secretion Diseases 0.000 description 6
- 206010046914 Vaginal infection Diseases 0.000 description 6
- 230000036772 blood pressure Effects 0.000 description 6
- 230000007812 deficiency Effects 0.000 description 6
- 150000002338 glycosides Chemical class 0.000 description 6
- 210000002216 heart Anatomy 0.000 description 6
- 210000002429 large intestine Anatomy 0.000 description 6
- 230000014759 maintenance of location Effects 0.000 description 6
- 230000001717 pathogenic effect Effects 0.000 description 6
- 230000000144 pharmacologic effect Effects 0.000 description 6
- 208000026435 phlegm Diseases 0.000 description 6
- 230000003014 reinforcing effect Effects 0.000 description 6
- 208000006820 Arthralgia Diseases 0.000 description 5
- 206010012735 Diarrhoea Diseases 0.000 description 5
- 210000001015 abdomen Anatomy 0.000 description 5
- 230000000840 anti-viral effect Effects 0.000 description 5
- 208000010668 atopic eczema Diseases 0.000 description 5
- 210000000988 bone and bone Anatomy 0.000 description 5
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 5
- 229960001231 choline Drugs 0.000 description 5
- 230000002708 enhancing effect Effects 0.000 description 5
- 235000019197 fats Nutrition 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- 238000002347 injection Methods 0.000 description 5
- 239000007924 injection Substances 0.000 description 5
- 201000007227 lymph node tuberculosis Diseases 0.000 description 5
- 208000004396 mastitis Diseases 0.000 description 5
- 244000045947 parasite Species 0.000 description 5
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 5
- 229930182490 saponin Natural products 0.000 description 5
- 150000007949 saponins Chemical class 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 210000002700 urine Anatomy 0.000 description 5
- 238000010792 warming Methods 0.000 description 5
- YRAQEMCYCSSHJG-NSHDSACASA-N (S)-columbianetin Chemical compound C1=CC(=O)OC2=C1C=CC1=C2C[C@@H](C(C)(O)C)O1 YRAQEMCYCSSHJG-NSHDSACASA-N 0.000 description 4
- BAHMQESJBKGPTE-UHFFFAOYSA-N 1,5,8-trimethyl-3a,4-dihydroazuleno[6,5-b]furan-2,6-dione Chemical compound C1C2OC(=O)C(C)=C2C=C2C(C)=CC(=O)C2=C1C BAHMQESJBKGPTE-UHFFFAOYSA-N 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 4
- 241000721047 Danaus plexippus Species 0.000 description 4
- 208000000059 Dyspnea Diseases 0.000 description 4
- 206010013975 Dyspnoeas Diseases 0.000 description 4
- 201000000297 Erysipelas Diseases 0.000 description 4
- 206010021118 Hypotonia Diseases 0.000 description 4
- 206010023126 Jaundice Diseases 0.000 description 4
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 230000000259 anti-tumor effect Effects 0.000 description 4
- 208000002894 beriberi Diseases 0.000 description 4
- 230000001276 controlling effect Effects 0.000 description 4
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 4
- 230000004438 eyesight Effects 0.000 description 4
- 208000017561 flaccidity Diseases 0.000 description 4
- 150000004676 glycans Chemical class 0.000 description 4
- 210000001624 hip Anatomy 0.000 description 4
- 230000036039 immunity Effects 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 230000002147 killing effect Effects 0.000 description 4
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 4
- 210000003205 muscle Anatomy 0.000 description 4
- 244000052769 pathogen Species 0.000 description 4
- 229920001282 polysaccharide Polymers 0.000 description 4
- 239000005017 polysaccharide Substances 0.000 description 4
- 206010036596 premature ejaculation Diseases 0.000 description 4
- 201000007094 prostatitis Diseases 0.000 description 4
- 210000004706 scrotum Anatomy 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 210000003932 urinary bladder Anatomy 0.000 description 4
- 239000000341 volatile oil Substances 0.000 description 4
- 206010063409 Acarodermatitis Diseases 0.000 description 3
- 206010003011 Appendicitis Diseases 0.000 description 3
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 3
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 3
- 206010027514 Metrorrhagia Diseases 0.000 description 3
- 201000007100 Pharyngitis Diseases 0.000 description 3
- 208000008350 Pruritus Vulvae Diseases 0.000 description 3
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 3
- 241000447727 Scabies Species 0.000 description 3
- 206010040943 Skin Ulcer Diseases 0.000 description 3
- 208000005392 Spasm Diseases 0.000 description 3
- 201000008100 Vaginitis Diseases 0.000 description 3
- 206010056530 Vulvovaginal pruritus Diseases 0.000 description 3
- 229930013930 alkaloid Natural products 0.000 description 3
- 150000003797 alkaloid derivatives Chemical class 0.000 description 3
- 230000000767 anti-ulcer Effects 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 206010006451 bronchitis Diseases 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 206010013990 dysuria Diseases 0.000 description 3
- 206010016256 fatigue Diseases 0.000 description 3
- 229930003935 flavonoid Natural products 0.000 description 3
- 150000002215 flavonoids Chemical class 0.000 description 3
- 235000017173 flavonoids Nutrition 0.000 description 3
- 210000004392 genitalia Anatomy 0.000 description 3
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 3
- 239000001685 glycyrrhizic acid Substances 0.000 description 3
- 229960004949 glycyrrhizic acid Drugs 0.000 description 3
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 3
- 235000019410 glycyrrhizin Nutrition 0.000 description 3
- 208000006454 hepatitis Diseases 0.000 description 3
- 210000003026 hypopharynx Anatomy 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 230000007803 itching Effects 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000010791 quenching Methods 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 208000005687 scabies Diseases 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 206010040872 skin infection Diseases 0.000 description 3
- 231100000019 skin ulcer Toxicity 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 230000035922 thirst Effects 0.000 description 3
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- OQIOHYHRGZNZCW-UHFFFAOYSA-N 2-methyl-5-propan-2-ylbenzene-1,4-diol Chemical compound CC(C)C1=CC(O)=C(C)C=C1O OQIOHYHRGZNZCW-UHFFFAOYSA-N 0.000 description 2
- OIGWAXDAPKFNCQ-UHFFFAOYSA-N 4-isopropylbenzyl alcohol Chemical compound CC(C)C1=CC=C(CO)C=C1 OIGWAXDAPKFNCQ-UHFFFAOYSA-N 0.000 description 2
- 208000030507 AIDS Diseases 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 206010000077 Abdominal mass Diseases 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- 206010001580 Albuminuria Diseases 0.000 description 2
- 206010003693 Atrophic vulvovaginitis Diseases 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 208000001387 Causalgia Diseases 0.000 description 2
- 208000023890 Complex Regional Pain Syndromes Diseases 0.000 description 2
- 206010010741 Conjunctivitis Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- WIONIXOBNMDJFJ-UHFFFAOYSA-N Dictamnine Chemical compound C1=CC=C2C(OC)=C(C=CO3)C3=NC2=C1 WIONIXOBNMDJFJ-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 208000015220 Febrile disease Diseases 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 208000007882 Gastritis Diseases 0.000 description 2
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 2
- 208000008454 Hyperhidrosis Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 208000026350 Inborn Genetic disease Diseases 0.000 description 2
- 239000005639 Lauric acid Substances 0.000 description 2
- WNGSUWLDMZFYNZ-UHFFFAOYSA-N Leonurine Chemical compound COC1=CC(C(=O)OCCCCN=C(N)N)=CC(OC)=C1O WNGSUWLDMZFYNZ-UHFFFAOYSA-N 0.000 description 2
- WWNNZCOKKKDOPX-UHFFFAOYSA-N N-methylnicotinate Chemical compound C[N+]1=CC=CC(C([O-])=O)=C1 WWNNZCOKKKDOPX-UHFFFAOYSA-N 0.000 description 2
- HPUXDMUGCAWDFW-UHFFFAOYSA-N Osthole Natural products COc1ccc2CCC(=O)Oc2c1C=CC(=O)C HPUXDMUGCAWDFW-UHFFFAOYSA-N 0.000 description 2
- 244000046052 Phaseolus vulgaris Species 0.000 description 2
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 2
- 206010061926 Purulence Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 208000025747 Rheumatic disease Diseases 0.000 description 2
- 208000019802 Sexually transmitted disease Diseases 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 229930182558 Sterol Natural products 0.000 description 2
- 241000193998 Streptococcus pneumoniae Species 0.000 description 2
- YRAQEMCYCSSHJG-UHFFFAOYSA-N Tetrahydro-oroselol Natural products C1=CC(=O)OC2=C1C=CC1=C2CC(C(C)(O)C)O1 YRAQEMCYCSSHJG-UHFFFAOYSA-N 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 201000007096 Vulvovaginal Candidiasis Diseases 0.000 description 2
- 206010071212 Vulvovaginal injury Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 208000019790 abdominal distention Diseases 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000000507 anthelmentic effect Effects 0.000 description 2
- 230000003288 anthiarrhythmic effect Effects 0.000 description 2
- 230000001088 anti-asthma Effects 0.000 description 2
- 230000001754 anti-pyretic effect Effects 0.000 description 2
- 230000002180 anti-stress Effects 0.000 description 2
- 239000002221 antipyretic Substances 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 208000019902 chronic diarrheal disease Diseases 0.000 description 2
- HIPIENNKVJCMAP-UHFFFAOYSA-N chrysanthemol Chemical compound CC(C)=CC1C(CO)C1(C)C HIPIENNKVJCMAP-UHFFFAOYSA-N 0.000 description 2
- 208000014439 complex regional pain syndrome type 2 Diseases 0.000 description 2
- 230000008602 contraction Effects 0.000 description 2
- 206010061428 decreased appetite Diseases 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 208000016361 genetic disease Diseases 0.000 description 2
- QBKSWRVVCFFDOT-UHFFFAOYSA-N gossypol Chemical compound CC(C)C1=C(O)C(O)=C(C=O)C2=C(O)C(C=3C(O)=C4C(C=O)=C(O)C(O)=C(C4=CC=3C)C(C)C)=C(C)C=C21 QBKSWRVVCFFDOT-UHFFFAOYSA-N 0.000 description 2
- 208000035861 hematochezia Diseases 0.000 description 2
- 231100000283 hepatitis Toxicity 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- 201000005630 leukorrhea Diseases 0.000 description 2
- 235000001510 limonene Nutrition 0.000 description 2
- 229940087305 limonene Drugs 0.000 description 2
- 229960004488 linolenic acid Drugs 0.000 description 2
- 201000003265 lymphadenitis Diseases 0.000 description 2
- 201000004792 malaria Diseases 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000004089 microcirculation Effects 0.000 description 2
- 210000004877 mucosa Anatomy 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- MBRLOUHOWLUMFF-UHFFFAOYSA-N osthole Chemical compound C1=CC(=O)OC2=C(CC=C(C)C)C(OC)=CC=C21 MBRLOUHOWLUMFF-UHFFFAOYSA-N 0.000 description 2
- 201000010808 postmenopausal atrophic vaginitis Diseases 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- ZCCUUQDIBDJBTK-UHFFFAOYSA-N psoralen Chemical compound C1=C2OC(=O)C=CC2=CC2=C1OC=C2 ZCCUUQDIBDJBTK-UHFFFAOYSA-N 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 230000001047 pyretic effect Effects 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 210000004994 reproductive system Anatomy 0.000 description 2
- 230000000552 rheumatic effect Effects 0.000 description 2
- 208000013220 shortness of breath Diseases 0.000 description 2
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 2
- 210000000813 small intestine Anatomy 0.000 description 2
- 230000035943 smell Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 235000003702 sterols Nutrition 0.000 description 2
- 238000007920 subcutaneous administration Methods 0.000 description 2
- 208000006379 syphilis Diseases 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 208000019206 urinary tract infection Diseases 0.000 description 2
- 206010046901 vaginal discharge Diseases 0.000 description 2
- 239000002435 venom Substances 0.000 description 2
- 231100000611 venom Toxicity 0.000 description 2
- 210000001048 venom Anatomy 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- 210000003905 vulva Anatomy 0.000 description 2
- DSNIKOZTDZBWKD-XMNJDQQWSA-N yejuhua lactone Chemical compound O([C@H]1C2C[C@H]([C@@](C3C1C(=CC3)C)(C)O)OC(=O)C)C(=O)C2(C1(C)C=C2)CC22C1[C@H]1OC(=O)C(=C)C1CC[C@@]2(C)O DSNIKOZTDZBWKD-XMNJDQQWSA-N 0.000 description 2
- XWMMEBCFHUKHEX-MRTCRTFGSA-N (+)-Taraxasterol Chemical compound C([C@@]12C)C[C@H](O)C(C)(C)[C@@H]1CC[C@]1(C)[C@@H]2CC[C@H]2[C@@H]3[C@H](C)C(=C)CC[C@]3(C)CC[C@]21C XWMMEBCFHUKHEX-MRTCRTFGSA-N 0.000 description 1
- KZJWDPNRJALLNS-VPUBHVLGSA-N (-)-beta-Sitosterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@@H](C(C)C)CC)C)CC4)CC3)CC=2)CC1 KZJWDPNRJALLNS-VPUBHVLGSA-N 0.000 description 1
- CSVWWLUMXNHWSU-UHFFFAOYSA-N (22E)-(24xi)-24-ethyl-5alpha-cholest-22-en-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(CC)C(C)C)C1(C)CC2 CSVWWLUMXNHWSU-UHFFFAOYSA-N 0.000 description 1
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- JRHJXXLCNATYLS-SOOLLQOPSA-N (2s,6s,7ar)-2-[(2e,4e,6e,8e,10e,12e,14e,16e)-17-[(1r,4r)-4-hydroxy-2,6,6-trimethylcyclohex-2-en-1-yl]-6,11,15-trimethylheptadeca-2,4,6,8,10,12,14,16-octaen-2-yl]-4,4,7a-trimethyl-2,5,6,7-tetrahydro-1-benzofuran-6-ol Chemical compound C/C([C@@H]1C=C2C(C)(C)C[C@H](O)C[C@@]2(C)O1)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C JRHJXXLCNATYLS-SOOLLQOPSA-N 0.000 description 1
- QMKPCZNFLUQTJZ-UHFFFAOYSA-N (4aR)-10c-Hydroxy-1t.2c.4ar.6at.6bc.9.9.12ac-octamethyl-(8atH.12btH.14acH.14btH)-docosahydro-picen Natural products CC1CCC2(C)CCC3(C)C(CCC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C QMKPCZNFLUQTJZ-UHFFFAOYSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- XYHKNCXZYYTLRG-UHFFFAOYSA-N 1h-imidazole-2-carbaldehyde Chemical compound O=CC1=NC=CN1 XYHKNCXZYYTLRG-UHFFFAOYSA-N 0.000 description 1
- HIXDQWDOVZUNNA-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-hydroxy-7-methoxychromen-4-one Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(OC)C(OC)=C1 HIXDQWDOVZUNNA-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- KLEXDBGYSOIREE-UHFFFAOYSA-N 24xi-n-propylcholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CCC)C(C)C)C1(C)CC2 KLEXDBGYSOIREE-UHFFFAOYSA-N 0.000 description 1
- GOLORTLGFDVFDW-UHFFFAOYSA-N 3-(1h-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one Chemical compound C1=CC=C2NC(C3=CC4=CC=C(C=C4OC3=O)N(CC)CC)=NC2=C1 GOLORTLGFDVFDW-UHFFFAOYSA-N 0.000 description 1
- GWYFCOCPABKNJV-UHFFFAOYSA-M 3-Methylbutanoic acid Natural products CC(C)CC([O-])=O GWYFCOCPABKNJV-UHFFFAOYSA-M 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- LEEZDPXWPYCRRM-UHFFFAOYSA-N 3-hydroxy-beta-eudesmol Natural products C1CC(O)C(=C)C2CC(C(C)(O)C)CCC21C LEEZDPXWPYCRRM-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 1
- VXGRJERITKFWPL-UHFFFAOYSA-N 4',5'-Dihydropsoralen Natural products C1=C2OC(=O)C=CC2=CC2=C1OCC2 VXGRJERITKFWPL-UHFFFAOYSA-N 0.000 description 1
- KSDSYIXRWHRPMN-UHFFFAOYSA-N 4'-O-beta-D-Galactopyranoside-6''-p-Coumaroylprunin-4',5,7-Trihydroxyflavanone Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC(O)=C3C(=O)C2)C=C1 KSDSYIXRWHRPMN-UHFFFAOYSA-N 0.000 description 1
- YFVGIJBUXMQFOF-PJOVQGMDSA-N 5-hydroxy-2-(4-methoxyphenyl)-7-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-[[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxychromen-4-one Chemical compound C1=CC(OC)=CC=C1C(OC1=C2)=CC(=O)C1=C(O)C=C2O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)O1 YFVGIJBUXMQFOF-PJOVQGMDSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 244000307697 Agrimonia eupatoria Species 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 241001480043 Arthrodermataceae Species 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 208000004926 Bacterial Vaginosis Diseases 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- SGNBVLSWZMBQTH-FGAXOLDCSA-N Campesterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@H](C(C)C)C)C)CC4)CC3)CC=2)CC1 SGNBVLSWZMBQTH-FGAXOLDCSA-N 0.000 description 1
- 206010007134 Candida infections Diseases 0.000 description 1
- WLYGSPLCNKYESI-RSUQVHIMSA-N Carthamin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1[C@@]1(O)C(O)=C(C(=O)\C=C\C=2C=CC(O)=CC=2)C(=O)C(\C=C\2C([C@](O)([C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C(O)=C(C(=O)\C=C\C=3C=CC(O)=CC=3)C/2=O)=O)=C1O WLYGSPLCNKYESI-RSUQVHIMSA-N 0.000 description 1
- DYQVDISPPLTLLR-HJQYTNQXSA-N Carthamin Natural products CC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)[C@]2(O)C(=C(C=C/3C(=O)C(=C(O)[C@](O)([C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C3=O)C(=O)C=Cc5ccc(O)cc5)C(=O)C(=C2O)C(=O)C=Cc6ccc(O)cc6)O DYQVDISPPLTLLR-HJQYTNQXSA-N 0.000 description 1
- 102000009660 Cholinergic Receptors Human genes 0.000 description 1
- 108010009685 Cholinergic Receptors Proteins 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- IFYMEZNJCAQUME-APKWKYNESA-N Chrysanthemaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C1OC2(C)CC(O)CC(C)(C)C2=C1)C=CC=C(/C)C=CC3=C(C)CC(O)CC3(C)C IFYMEZNJCAQUME-APKWKYNESA-N 0.000 description 1
- 229930008410 Chrysanthemol Natural products 0.000 description 1
- 244000192528 Chrysanthemum parthenium Species 0.000 description 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- LPZCCMIISIBREI-MTFRKTCUSA-N Citrostadienol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4[C@H](C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C LPZCCMIISIBREI-MTFRKTCUSA-N 0.000 description 1
- 206010010075 Coma hepatic Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 241000186216 Corynebacterium Species 0.000 description 1
- RKWHWFONKJEUEF-GQUPQBGVSA-O Cyanidin 3-O-glucoside Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC2=C(O)C=C(O)C=C2[O+]=C1C1=CC=C(O)C(O)=C1 RKWHWFONKJEUEF-GQUPQBGVSA-O 0.000 description 1
- ARVGMISWLZPBCH-UHFFFAOYSA-N Dehydro-beta-sitosterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(CC)C(C)C)CCC33)C)C3=CC=C21 ARVGMISWLZPBCH-UHFFFAOYSA-N 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 1
- QNGQIURXCUHNAT-UHFFFAOYSA-N Eucarvone Chemical compound CC1=CC=CC(C)(C)CC1=O QNGQIURXCUHNAT-UHFFFAOYSA-N 0.000 description 1
- OPQCAZJRIRHZQK-UHFFFAOYSA-N Eucarvone Natural products CC1=CC=CCC(C)(C)C1=O OPQCAZJRIRHZQK-UHFFFAOYSA-N 0.000 description 1
- VWJYWGYJIDQUEG-DKDOXNMLSA-N Eupatoriopicrin Chemical compound OC/C=C(\CO)C(=O)O[C@@H]1C\C(C)=C\CCC(/C)=C/[C@H]2OC(=O)C(=C)[C@@H]21 VWJYWGYJIDQUEG-DKDOXNMLSA-N 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 206010016717 Fistula Diseases 0.000 description 1
- 241000237858 Gastropoda Species 0.000 description 1
- 239000005792 Geraniol Substances 0.000 description 1
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- BTEISVKTSQLKST-UHFFFAOYSA-N Haliclonasterol Natural products CC(C=CC(C)C(C)(C)C)C1CCC2C3=CC=C4CC(O)CCC4(C)C3CCC12C BTEISVKTSQLKST-UHFFFAOYSA-N 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010061217 Infestation Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- ZUKLFFYDSALIQW-MSUKCBDUSA-N Iridoid glycoside Chemical compound [H][C@]12CC[C@H](C(O)=O)[C@@]1([H])[C@H](OC1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)OC=C2 ZUKLFFYDSALIQW-MSUKCBDUSA-N 0.000 description 1
- RNKZFOIQKCQOAQ-UHFFFAOYSA-N Isopimpinellin Natural products COC1CC(=O)Oc2c(OC)c3occc3cc12 RNKZFOIQKCQOAQ-UHFFFAOYSA-N 0.000 description 1
- CMUNUTVVOOHQPW-LURJTMIESA-N L-proline betaine Chemical compound C[N+]1(C)CCC[C@H]1C([O-])=O CMUNUTVVOOHQPW-LURJTMIESA-N 0.000 description 1
- VELYAQRXBJLJAK-MJSCJBMMSA-N Leonuridine Chemical compound C12C(C)(O)CC(O)C2C=COC1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VELYAQRXBJLJAK-MJSCJBMMSA-N 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- 241000589902 Leptospira Species 0.000 description 1
- YFVGIJBUXMQFOF-SAXLCNSLSA-N Linarin Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@H](Oc2cc(O)c3C(=O)C=C(c4ccc(OC)cc4)Oc3c2)O1)[C@H]1[C@@H](O)[C@@H](O)[C@@H](O)[C@H](C)O1 YFVGIJBUXMQFOF-SAXLCNSLSA-N 0.000 description 1
- DEMKZLAVQYISIA-ONJCETCRSA-N Liquiritin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)c1ccc([C@@H]2Oc3c(C(=O)C2)ccc(O)c3)cc1 DEMKZLAVQYISIA-ONJCETCRSA-N 0.000 description 1
- DEMKZLAVQYISIA-UHFFFAOYSA-N Liquirtin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-UHFFFAOYSA-N 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 208000008763 Mercury poisoning Diseases 0.000 description 1
- QXKHYNVANLEOEG-UHFFFAOYSA-N Methoxsalen Chemical compound C1=CC(=O)OC2=C1C=C1C=COC1=C2OC QXKHYNVANLEOEG-UHFFFAOYSA-N 0.000 description 1
- BYBLEWFAAKGYCD-UHFFFAOYSA-N Miconazole Chemical compound ClC1=CC(Cl)=CC=C1COC(C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 BYBLEWFAAKGYCD-UHFFFAOYSA-N 0.000 description 1
- 241000192041 Micrococcus Species 0.000 description 1
- 208000005647 Mumps Diseases 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 208000009525 Myocarditis Diseases 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- YYSRTHIUABRSAB-UHFFFAOYSA-N Neocarthamin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=C(O)C2=C1C(=O)CC(C=1C=CC(O)=CC=1)O2 YYSRTHIUABRSAB-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- HIGQPQRQIQDZMP-DHZHZOJOSA-N Neryl acetate Natural products CC(C)=CCC\C(C)=C\COC(C)=O HIGQPQRQIQDZMP-DHZHZOJOSA-N 0.000 description 1
- 208000001140 Night Blindness Diseases 0.000 description 1
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 206010033425 Pain in extremity Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 239000006002 Pepper Substances 0.000 description 1
- 235000016761 Piper aduncum Nutrition 0.000 description 1
- 235000017804 Piper guineense Nutrition 0.000 description 1
- 244000203593 Piper nigrum Species 0.000 description 1
- 235000008184 Piper nigrum Nutrition 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 241000219000 Populus Species 0.000 description 1
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 1
- 241000588769 Proteus <enterobacteria> Species 0.000 description 1
- 208000007313 Reproductive Tract Infections Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 241001423398 Ruscus hypoglossum Species 0.000 description 1
- 206010039424 Salivary hypersecretion Diseases 0.000 description 1
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 1
- 206010049677 Salpingo-oophoritis Diseases 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- SLSIBLKBHNKZTB-UHFFFAOYSA-N Skimmianine Chemical compound COC1=C2C=COC2=NC2=C(OC)C(OC)=CC=C21 SLSIBLKBHNKZTB-UHFFFAOYSA-N 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- UQZIYBXSHAGNOE-USOSMYMVSA-N Stachyose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO[C@@H]2[C@@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O2)O1 UQZIYBXSHAGNOE-USOSMYMVSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- QHOPXUFELLHKAS-UHFFFAOYSA-N Thespesin Natural products CC(C)c1c(O)c(O)c2C(O)Oc3c(c(C)cc1c23)-c1c2OC(O)c3c(O)c(O)c(C(C)C)c(cc1C)c23 QHOPXUFELLHKAS-UHFFFAOYSA-N 0.000 description 1
- 208000009453 Thyroid Nodule Diseases 0.000 description 1
- 208000024770 Thyroid neoplasm Diseases 0.000 description 1
- 241000223238 Trichophyton Species 0.000 description 1
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 1
- 208000006374 Uterine Cervicitis Diseases 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 206010046910 Vaginal haemorrhage Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- PCWZKQSKUXXDDJ-UHFFFAOYSA-N Xanthotoxin Natural products COCc1c2OC(=O)C=Cc2cc3ccoc13 PCWZKQSKUXXDDJ-UHFFFAOYSA-N 0.000 description 1
- 208000031975 Yang Deficiency Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- KGEKLUUHTZCSIP-HOSYDEDBSA-N [(1s,4s,6r)-1,7,7-trimethyl-6-bicyclo[2.2.1]heptanyl] acetate Chemical compound C1C[C@]2(C)[C@H](OC(=O)C)C[C@H]1C2(C)C KGEKLUUHTZCSIP-HOSYDEDBSA-N 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 201000004484 acute conjunctivitis Diseases 0.000 description 1
- 206010001093 acute tonsillitis Diseases 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 230000001800 adrenalinergic effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- FSLPMRQHCOLESF-UHFFFAOYSA-N alpha-amyrenol Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C)C(C)C5C4=CCC3C21C FSLPMRQHCOLESF-UHFFFAOYSA-N 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000489 anti-atherogenic effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000001986 anti-endotoxic effect Effects 0.000 description 1
- 230000001716 anti-fugal effect Effects 0.000 description 1
- 230000000702 anti-platelet effect Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 230000001572 anti-trichomonad Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 201000009361 ascariasis Diseases 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- RJWJHRPNHPHBRN-FKVJWERZSA-N aucubin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1[C@@H]2C(CO)=C[C@@H](O)[C@@H]2C=CO1 RJWJHRPNHPHBRN-FKVJWERZSA-N 0.000 description 1
- UTDFQMAXCUGNJR-UHFFFAOYSA-N aucubin Natural products OCC1OC(Oc2ccoc2C3C(O)CCC3O)C(O)C(O)C1O UTDFQMAXCUGNJR-UHFFFAOYSA-N 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N benzo-alpha-pyrone Natural products C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- MJVXAPPOFPTTCA-UHFFFAOYSA-N beta-Sistosterol Natural products CCC(CCC(C)C1CCC2C3CC=C4C(C)C(O)CCC4(C)C3CCC12C)C(C)C MJVXAPPOFPTTCA-UHFFFAOYSA-N 0.000 description 1
- JFSHUTJDVKUMTJ-QHPUVITPSA-N beta-amyrin Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C JFSHUTJDVKUMTJ-QHPUVITPSA-N 0.000 description 1
- QQFMRPIKDLHLKB-UHFFFAOYSA-N beta-amyrin Natural products CC1C2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C)CCC1(C)C QQFMRPIKDLHLKB-UHFFFAOYSA-N 0.000 description 1
- PDNLMONKODEGSE-UHFFFAOYSA-N beta-amyrin acetate Natural products CC(=O)OC1CCC2(C)C(CCC3(C)C4(C)CCC5(C)CCC(C)(C)CC5C4=CCC23C)C1(C)C PDNLMONKODEGSE-UHFFFAOYSA-N 0.000 description 1
- GWYFCOCPABKNJV-UHFFFAOYSA-N beta-methyl-butyric acid Natural products CC(C)CC(O)=O GWYFCOCPABKNJV-UHFFFAOYSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000019636 bitter flavor Nutrition 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 230000002308 calcification Effects 0.000 description 1
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 1
- SGNBVLSWZMBQTH-PODYLUTMSA-N campesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](C)C(C)C)[C@@]1(C)CC2 SGNBVLSWZMBQTH-PODYLUTMSA-N 0.000 description 1
- 235000000431 campesterol Nutrition 0.000 description 1
- 239000010238 camphora Substances 0.000 description 1
- 229940025250 camphora Drugs 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000005961 cardioprotection Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000032677 cell aging Effects 0.000 description 1
- 206010008323 cervicitis Diseases 0.000 description 1
- 210000003756 cervix mucus Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 201000001352 cholecystitis Diseases 0.000 description 1
- 230000001989 choleretic effect Effects 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 208000013507 chronic prostatitis Diseases 0.000 description 1
- YTMNONATNXDQJF-UBNZBFALSA-N chrysanthemin Chemical compound [Cl-].O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC2=C(O)C=C(O)C=C2[O+]=C1C1=CC=C(O)C(O)=C1 YTMNONATNXDQJF-UBNZBFALSA-N 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- DQISGWRLCDLKJI-UHFFFAOYSA-N columbianetin Natural products C1=CC(=O)OC2=C(C(C(C(C)(O)C)O3)O)C3=CC=C21 DQISGWRLCDLKJI-UHFFFAOYSA-N 0.000 description 1
- 235000000125 common agrimony Nutrition 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 229920002770 condensed tannin Polymers 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 150000004775 coumarins Chemical class 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000037304 dermatophytes Effects 0.000 description 1
- 238000000586 desensitisation Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 229910052571 earthenware Inorganic materials 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- WZCWQUPNPBJVFL-UHFFFAOYSA-N eupatoriopicrin Natural products CC1=C/C2OC(=O)C(=C)C2C(CC(=CCC1)C)OCC(=O)C(=CCO)CO WZCWQUPNPBJVFL-UHFFFAOYSA-N 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 208000024756 faint Diseases 0.000 description 1
- 239000010685 fatty oil Substances 0.000 description 1
- 235000008384 feverfew Nutrition 0.000 description 1
- 230000003890 fistula Effects 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 229930182486 flavonoid glycoside Natural products 0.000 description 1
- 150000007955 flavonoid glycosides Chemical class 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 210000002683 foot Anatomy 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- 208000003512 furunculosis Diseases 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 230000005176 gastrointestinal motility Effects 0.000 description 1
- HIGQPQRQIQDZMP-UHFFFAOYSA-N geranil acetate Natural products CC(C)=CCCC(C)=CCOC(C)=O HIGQPQRQIQDZMP-UHFFFAOYSA-N 0.000 description 1
- 229940113087 geraniol Drugs 0.000 description 1
- XTLWNMXYCHABQH-UHFFFAOYSA-N germanicol Natural products CC1(C)CCC2(C)CCC3(C)C(CCC4(C)C5(C)CCC(O)C(C)(C)C5CCC34C)C2=C1 XTLWNMXYCHABQH-UHFFFAOYSA-N 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 210000002149 gonad Anatomy 0.000 description 1
- 230000001456 gonadotroph Effects 0.000 description 1
- 229930000755 gossypol Natural products 0.000 description 1
- 229950005277 gossypol Drugs 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 201000001059 hepatic coma Diseases 0.000 description 1
- 208000007386 hepatic encephalopathy Diseases 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- XMHIUKTWLZUKEX-UHFFFAOYSA-N hexacosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCC(O)=O XMHIUKTWLZUKEX-UHFFFAOYSA-N 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000037315 hyperhidrosis Effects 0.000 description 1
- 230000037189 immune system physiology Effects 0.000 description 1
- 239000002955 immunomodulating agent Substances 0.000 description 1
- 230000002584 immunomodulator Effects 0.000 description 1
- 229940121354 immunomodulator Drugs 0.000 description 1
- 230000001506 immunosuppresive effect Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 208000000509 infertility Diseases 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 231100000535 infertility Toxicity 0.000 description 1
- 208000021267 infertility disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000000749 insecticidal effect Effects 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 239000002799 interferon inducing agent Substances 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- 229930182489 iridoid glycoside Natural products 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- DFMAXQKDIGCMTL-UHFFFAOYSA-N isopimpinellin Chemical compound O1C(=O)C=CC2=C1C(OC)=C1OC=CC1=C2OC DFMAXQKDIGCMTL-UHFFFAOYSA-N 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 230000000292 leukogenic effect Effects 0.000 description 1
- KBDSLGBFQAGHBE-MSGMIQHVSA-N limonin Chemical compound C=1([C@H]2[C@]3(C)CC[C@H]4[C@@]([C@@]53O[C@@H]5C(=O)O2)(C)C(=O)C[C@@H]2[C@]34COC(=O)C[C@@H]3OC2(C)C)C=COC=1 KBDSLGBFQAGHBE-MSGMIQHVSA-N 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- DEMKZLAVQYISIA-ZRWXNEIDSA-N liquiritin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C([C@H]2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-ZRWXNEIDSA-N 0.000 description 1
- 239000003589 local anesthetic agent Substances 0.000 description 1
- 238000011866 long-term treatment Methods 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- LRDGATPGVJTWLJ-UHFFFAOYSA-N luteolin Natural products OC1=CC(O)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 LRDGATPGVJTWLJ-UHFFFAOYSA-N 0.000 description 1
- 235000009498 luteolin Nutrition 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000007257 malfunction Effects 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000008558 metabolic pathway by substance Effects 0.000 description 1
- 229960004469 methoxsalen Drugs 0.000 description 1
- SQBBOVROCFXYBN-UHFFFAOYSA-N methoxypsoralen Natural products C1=C2OC(=O)C(OC)=CC2=CC2=C1OC=C2 SQBBOVROCFXYBN-UHFFFAOYSA-N 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- 229960000282 metronidazole Drugs 0.000 description 1
- VAOCPAMSLUNLGC-UHFFFAOYSA-N metronidazole Chemical compound CC1=NC=C([N+]([O-])=O)N1CCO VAOCPAMSLUNLGC-UHFFFAOYSA-N 0.000 description 1
- 229960002509 miconazole Drugs 0.000 description 1
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 1
- 208000010805 mumps infectious disease Diseases 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- LRHPLDYGYMQRHN-UHFFFAOYSA-N n-Butanol Substances CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 1
- UBFTZAGDGOMJQE-SACPXRHSSA-N neocarthamin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C(O)C(O)=CC2=C1C(=O)C[C@@H](C=1C=CC(O)=CC=1)O2 UBFTZAGDGOMJQE-SACPXRHSSA-N 0.000 description 1
- HIGQPQRQIQDZMP-FLIBITNWSA-N neryl acetate Chemical compound CC(C)=CCC\C(C)=C/COC(C)=O HIGQPQRQIQDZMP-FLIBITNWSA-N 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- PMOWTIHVNWZYFI-UHFFFAOYSA-N o-Coumaric acid Natural products OC(=O)C=CC1=CC=CC=C1O PMOWTIHVNWZYFI-UHFFFAOYSA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 229940100243 oleanolic acid Drugs 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 229940126701 oral medication Drugs 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- HFPZCAJZSCWRBC-UHFFFAOYSA-N p-cymene Chemical compound CC(C)C1=CC=C(C)C=C1 HFPZCAJZSCWRBC-UHFFFAOYSA-N 0.000 description 1
- AZQWKYJCGOJGHM-UHFFFAOYSA-N para-benzoquinone Natural products O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229960000292 pectin Drugs 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 1
- 230000004224 protection Effects 0.000 description 1
- NGFFRJBGMSPDMS-UHFFFAOYSA-N psi-Taraxasterol Natural products CC12CCC(O)C(C)(C)C1CCC1(C)C2CCC2C3C(C)C(C)=CCC3(C)CCC21C NGFFRJBGMSPDMS-UHFFFAOYSA-N 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 235000020995 raw meat Nutrition 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229940056692 resinol Drugs 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 208000026451 salivation Diseases 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 235000011649 selenium Nutrition 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 235000015500 sitosterol Nutrition 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 description 1
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- GSZUGBAEBARHAW-UHFFFAOYSA-N sophoraflavone B Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C=2OC3=CC(O)=CC=C3C(=O)C=2)C=C1 GSZUGBAEBARHAW-UHFFFAOYSA-N 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 235000021259 spicy food Nutrition 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- CMUNUTVVOOHQPW-ZCFIWIBFSA-N stachydrine Natural products C[N+]1(C)CCC[C@@H]1C([O-])=O CMUNUTVVOOHQPW-ZCFIWIBFSA-N 0.000 description 1
- UQZIYBXSHAGNOE-XNSRJBNMSA-N stachyose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO[C@@H]3[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O3)O)O2)O)O1 UQZIYBXSHAGNOE-XNSRJBNMSA-N 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 1
- 229940032091 stigmasterol Drugs 0.000 description 1
- 235000016831 stigmasterol Nutrition 0.000 description 1
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 1
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- HUTYZQWCTWWXND-NCTFTGAASA-N taraxasterol Natural products C[C@H]1[C@H]2C3=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]4(C)[C@]3(C)C[C@H](O)[C@@]2(C)CCC1=C HUTYZQWCTWWXND-NCTFTGAASA-N 0.000 description 1
- GGGUGZHBAOMSFJ-GADYQYKKSA-N taraxerol Chemical compound CC([C@@H]1CC2)(C)[C@@H](O)CC[C@]1(C)[C@@H]1[C@]2(C)C2=CC[C@@]3(C)CCC(C)(C)C[C@H]3[C@]2(C)CC1 GGGUGZHBAOMSFJ-GADYQYKKSA-N 0.000 description 1
- HYTFUKZLSYXRDX-UHFFFAOYSA-N taraxerol Natural products CC1CCCC2C3(C)CCC4(C)C5CC(C)(C)CCC5(C)C=CC4(C)C3C(O)CC12C HYTFUKZLSYXRDX-UHFFFAOYSA-N 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 235000015961 tonic Nutrition 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- PMOWTIHVNWZYFI-AATRIKPKSA-N trans-2-coumaric acid Chemical compound OC(=O)\C=C\C1=CC=CC=C1O PMOWTIHVNWZYFI-AATRIKPKSA-N 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 150000008130 triterpenoid saponins Chemical class 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 235000016804 zinc Nutrition 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种治疗生殖性疾病的化毒和菌中药组合物及其制备方法。以重量份表示,本发明治疗生殖性疾病的化毒和菌中药组合物主要由原料药山药35~45份,野菊花35~45份,煅阴起石35~45份,煅阳起石35~45份,淫阳藿25~35份,二花25~35份,黄柏25~35份,土茯苓15~25份,川椒15~25份,蒲公英15~25份,益母草15~25份,苍术15~25份,紫花地丁25~35份,连翘25~35份,槟榔25~35份,人参35~45份,黄芪25~35份,红花10~20份,白花蛇舌草25~35份,甘草10~20份,佩兰10~20份,车前子15~25份,白藓皮25~35份,蛇床子25~35份,苦参25~35份和芒硝65~75份制备而成。利用本发明药物治疗生殖性疾病治愈率较高,有效率达98%,治愈率达90%以上,治愈后由原来传统方法复发率80%降低到20%以下。因此,利用本发明药物治疗生殖性疾病,具有显著疗效。
Description
技术领域
本发明涉及一种中药组合物,特别是涉及一种治疗生殖性疾病的化毒和菌中药组合物及其制备方法。
背景技术
妇科是世界上性传播疾病和传染病的多发地区,75%以上的妇女有着不同程度的妇科疾病。以外阴瘙痒、阴道炎包括滴虫性阴道炎、霉菌性阴道炎、念珠菌性阴道炎、阿米巴性阴道炎、老年性阴道炎和盆腔炎、宫颈炎及附件炎等最多、最普遍。可以说妇科病一直是我国一种多发病和常见病,统计资料表明妇科病在农村的发病率高达80%以上,在中小城市也有64%左右。生殖道感染为42.9%,盆腔炎占7%左右,严重影响着妇女同胞的工作和生活。针对妇科阴道炎、盆腔炎等常见病,经常使用的栓剂药物有达克宁栓、消糜栓、甲硝唑栓、康妇特栓,其多为抗生素类,在治疗过程中毒副作用大。
目前,也有较多用于治疗妇科生殖性疾病的中成药。例如:1、申请号为200710020483.1、发明名称为“一种治疗妇女生殖系统疾病的药物”的发明专利,该药物主要由鹤虱、蛇床子、苦参、白藓皮、蒲公英、金银花组成。2、申请号为01127559.6、发明名称为“治疗妇科生殖系统疾病的中药煎剂”的发明专利,该发明专利的药物主要由柴胡、白芍、栀子、龙胆草、当归、茯苓、泽泻、车前子、生地、山豆根、川黄连、肉桂、川大黄、麻黄、甘草、生石膏、桔梗和鱼腥草组成。但目前大都数中成药治疗效果不甚理想,并且复发率较高,治愈后复发率高达80%左右。因此,针对该情况,迫切需要研究开发更好的用于治疗生殖性系统疾病的药物。
发明内容
本发明要解决的技术问题是提供一种治疗生殖性疾病的中药组合物及其制备方法。本发明治疗生殖性疾病的中药组合物不仅对妇科生殖性疾病具有显著疗效,而且对男性生殖性疾病也有显著疗效。本发明对生殖性疾病具有有效防止男、女生殖性疾病而诱发的疾病(如盆腔炎、阴囊炎、前列腺炎等)。
为了解决上述问题,本发明采用的技术方案:
本发明提供一种治疗生殖性疾病的化毒和菌中药组合物,以重量份表示,所述治疗生殖性疾病的化毒和菌中药组合物由原料药山药35~45份,野菊花35~45份,煅阴起石35~45份,煅阳起石35~45份,淫阳藿25~35份,二花25~35份,黄柏25~35份,土茯苓15~25份,川椒15~25份,蒲公英15~25份,益母草15~25份,苍术15~25份,紫花地丁25~35份,连翘25~35份,槟榔25~35份,人参35~45份,黄芪25~35份,红花10~20份,白花蛇舌草25~35份,甘草10~20份,佩兰10~20份,车前子15~25份,白藓皮25~35份,蛇床子25~35份,苦参25~35份和芒硝65~75份组成。
根据上述的治疗生殖性疾病的化毒和菌中药组合物,所述治疗生殖性疾病的化毒和菌中药组合物由原料药山药38~42份,野菊花38~42份,煅阴起石38~42份,煅阳起石38~42份,淫阳藿28~32份,二花28~32份,黄柏28~32份,土茯苓18~22份,川椒18~22份,蒲公英18~22份,益母草18~22份,苍术18~22份,紫花地丁28~32份,连翘28~32份,槟榔28~32份,人参38~42份,黄芪28~32份,红花13~17份,白花蛇舌草28~32份,甘草13~17份,佩兰13~17份,车前子18~22份,白藓皮28~32份,蛇床子28~32份,苦参28~32份和芒硝68~72份组成。
根据上述的治疗生殖性疾病的化毒和菌中药组合物,所述治疗生殖性疾病的化毒和菌中药组合物由原料药山药40份,野菊花40份,煅阴起石40份,煅阳起石40份,淫阳霍30份,二花30份,黄柏30份,土茯苓20份,川椒20份,蒲公英20份,益母草20份,苍术20份,紫花地丁30份,连翘30份,槟榔30份,人参40份,黄芪30份,红花15份,白花蛇舌草30份,甘草15份,佩兰15份,车前子20份,白藓皮30份,蛇床子30份,苦参30份和芒硝70份组成。
一种治疗生殖性疾病的化毒和菌中药组合物的制备方法,所述制备方法包括以下步骤:
a、首先按照上述治疗生殖性疾病的化毒和菌中药组合物的配比比例称取各种原料药;
b、将步骤a称取的原料药淫阳藿先酒蒸30分钟,然后与原料药山药、野菊花、红花、人参、黄芪、甘草和益母草加入砂锅内,并加入清水,清水的加入量为所加入的原料药总重量的3~5倍,加入清水后进行加热煎煮25~35分钟,过滤后接着煮25~35分钟,煮后再进行过滤得到第一次上清液;按照同样的煎煮方法进行三次过滤处理,得到三次上清液,将三次得到的上清液混合均匀;接着将混合均匀的上清液熬制成膏状得到膏状药物,将膏状药物进行烘干粉碎,得到菌和膏粉;
c、将步骤a称取的原料药二花、白花蛇舌草、紫花地丁、黄柏、白藓皮、蒲公英、连翘和苦参放入砂锅,然后加入水浸泡50~70分钟,水的加入量是所加入的原料药总重量的5~8倍,浸泡后进行加热熬制,煮沸后熬制20~30分钟,熬制后进行过滤得到第一次滤液,按照同样的熬制方法连续熬制2~3次,将所得2~3次的滤液进行混合得到混合药液,将混合药液放入不带釉的瓦罐内,并将称取的原料药芒硝加入混合药液中,封严罐口,悬挂在阴凉通风处,待瓦罐外析出白色结晶物时进行收集,至无结晶物析出为止,将析出的白色结晶物全部收集,得到霜体药物即称之为毒清霜,储备待用;
d、将步骤a称取的原料药煅阴起石、煅阳起石、槟榔、川椒、蛇床子、佩兰、车前子、土茯苓和苍术分别粉碎,粉碎后混合均匀,最后加入纯粮酒焖制22~24小时,所加入的原料药的总重量与纯粮酒二者之间的重量比为1:1,焖制后得到稠糊状药物,取出按照栓剂常规方法制备成直径为1cm、长1.5cm的空心栓剂,将空心栓剂用火煅透存性备用;
e、将步骤b得到的菌和膏粉放入步骤d得到的空心栓剂内,空心栓剂外面用吸附性较强的细薄绢布包好,将步骤c得到的霜体药物即毒清霜置于细薄绢布之间,最后装入真空袋内密封,高压灭菌,灭菌后备用。
本发明采用的各种原料药的药理作用:
山药:本品味甘、性平,入肺、脾、肾经。功效主治:本品具有健脾补肺、益胃补肾、固肾益精、聪耳明目、助五脏、强筋骨、长志安神、延年益寿等功效。常用治脾胃虚弱、倦怠无力、食欲不振、久泄久痢、肺气虚燥、痰喘咳嗽、肾气亏耗、腰膝酸软、下肢痿弱、消渴尿频、遗精早泄、带下白浊、皮肤赤肿、肥胖等病症。
现代药理学研究证明:本品主要含有胆碱、三萜皂甙、尿囊素、淀粉、氨基酸等成分。本品具有健脾益胃、助消化,降血糖,抗肝昏迷,脱敏、消炎,抗菌、消炎,降血脂,抗肿瘤等作用。
野菊花:味苦、辛,性微寒,入肺、肝经。功效主治:具有清热解毒,疏风平肝等功效。常用治疔疮,痈疽,丹毒,湿疹,皮炎,风热感冒,咽喉肿痛,高血压病等证。
现代医学研究:甘草含含多种挥发油,包括樟烯、樟脑、葛缕酮、柠檬烯等,也含有蒙花甙、木犀草素甙,矢车菊甙、菊黄质、多糖、香豆精类、野菊花内酯等。野菊花是中草药中的“广谱抗生素”,对多数皮肤真菌、金黄色葡萄球菌、痢疾杆菌、绿脓杆菌和流感病毒等均有较强的抑制作用。野菊花为菊科植物野菊的头状花序,主要成分为野菊花内酯、野菊花醇、黄酮苷等,性微寒,具疏散风热、消肿解毒、抗感染、抗病毒的功效。中医认为,野菊花性凉,有疏风清热、解毒消肿、健脑明目等功效,可治疗冠心病、高血压、风热感冒、肺炎、鼻炎、支气管炎、咽喉肿痛、目赤模糊、淋巴腺炎、痈疖疔毒、湿疹、皮肤瘙痒、口疮、丹毒等症。
阴起石:本品味咸,性温;归肾经。功效主治:具有温补命门功效;常用治肾阳虚的阳痿,宫冷,腰膝冷痹等证。
煅阴起石:取净阴起石,置坩蜗或其它容器内,放无烟炉火上用武火煅至红透,取出,放凉,砸碎即可。
阳起石:本品味咸,性温;归肾经。功效主治:本品具有温肾壮阳之功效;常用治肾阳虚衰,阳痿,遗精,早泄,腰膝酸软,宫寒不孕,带下,症瘕,崩漏等证。
煅阳起石:取洁净的阳起石块,置坩埚内,在无烟的炉火中煅红透,倒入黄酒内淬,取出,晾干,碾细即可。
淫阳藿:淫阳藿:性温,味辛、甘,无毒;入肝、肾二经。功效主治:1、补肾助阳:淫阳藿性温不寒,能益精气,真阳不足者宜之。故常用之治疗肾阳不足之阳萎,遗精,遗尿,尿频等症。2、强筋健骨:淫阳藿甘温偏补,入肝肾经,能补益肝肾,筋健骨,故可用之治疗肝肾亏损之瘘废。3、祛风除湿:淫阳藿辛温之品,固不独益肾壮阳,并能通行经路,去除风寒湿痹。临床可用治风湿痹痛以及寒湿蕴结四肢拘急等症。4、洗疮杀虫。5、消瘰化痈。
二花:又名金银花,本品味甘、性寒,入肺、胃经。功效主治:具有清热解毒、疏散风热等作用。常用治温病发热,风热感冒,丹毒,热毒血痢,痈肿疔疮,喉痹及多种感染性疾病等证。
现代医学研究:本品含绿原酸类、甙类、黄酮类、挥发油类成分;甙类成分包括皂甙、环烯醚萜甙等,具有抗菌及抗病毒、增强免疫、抗炎、解热等功能,并且具有抗病原微生物、抗炎和解热、加强防御机能、降血脂以及抗内毒素等作用。
黄柏:本品味苦,性寒;入肾、膀胱、大肠经。功效主治:本品具有清热燥湿,泻火除蒸,解毒疗疮等功效。常用治湿热泻痢,黄疸,带下,热淋,脚气,痿辟,骨蒸痨热,盗汗,遗精,疮疡肿毒,湿疹瘙痒等症。
土茯苓:本品味甘淡,性平;归肝经、胃经和脾经。功效主治:本品具有解毒,除湿,利关节等功效;常用治梅毒,淋浊,筋骨挛痛,脚气,疔疗疮,痈肿,瘰疬,梅毒及汞中毒所致的肢体拘挛,筋骨疼痛等证。
现代医学研究:本品根茎含皂甙、鞣质、树脂等。具有抗肿瘤作用和对棉酚的解毒作用。
川椒:本品味辛、性温,归脾、胃、肾三经。功效主治:本品具有温中止痛、杀虫止痒等功效;常用治脘腹冷痛,呕吐泄泻,虫积腹痛,蛔虫症等证;外治湿疹瘙痒。
现代医学研究:本品果含挥发油(为柠檬烯、枯醇、香叶醇等)、淄醇,不饱和有机酸。本品具有除各种肉类的腥气;促进唾液分泌,增加食欲;使血管扩张,从而起到降低血压的作用;服花椒水能去除寄生虫;有芳香健胃、温中散寒、除湿止痛、杀虫解毒、止痒解腥的功效。
蒲公英:本品味甘、微苦,性寒。功效主治:本品具有清热解毒,消肿散结,利尿,缓泻,退黄疸,利胆等功效。常用治上呼吸道感染,眼结膜炎,流行性腮腺炎,高血糖,乳痈肿痛,胃炎,痢疾,肝炎,胆囊炎,急性阑尾炎,泌尿系感染,盆腔炎,痈疖疔疮,咽炎,急性乳腺炎,淋巴腺炎,瘰疬,疔毒疮肿,急性结膜炎,感冒发烧,急性扁桃体炎,急性支气管炎,尿路感染等症。
本品含蒲公英甾醇、胆碱、菊糖、果胶;蒲公英醇、豆甾醇、β-香树脂醇、β-谷甾醇、蒲公英赛醇、蒲公英素、蒲公英苦素和维生素A、B、C等。本品具有的药理作用:1、对肺炎双球菌、脑膜炎球菌、白喉杆菌、绿脓杆菌、变形杆菌、痢疾杆菌、伤寒杆菌等及卡他球菌亦有一定的杀菌作用;2、对某些真菌亦有抑制作用;2、保肝、利胆作用;3、抗胃溃疡作用;4、本品有抗人体肺癌作用。有促进妇女乳汁分泌作用。
益母草:本品味辛苦,性凉;入心、肝、膀胱经。功效主治:本品具有活血调经,利水消肿,清热解毒,祛瘀,消水等功效;常用治妇女月经不调,胎漏难产,胞衣不下,产后血晕,瘀血腹痛,崩中漏下,尿血、泻血,痈肿疮疡等证。
现代医学研究:本品主含益母草碱、水苏碱、益母草定、益母草宁、亚麻酸、β-亚麻酸、月桂酸、油酸、苯甲酸、芸香甙、延胡索酸、甾醇、维生素A等。此外亦含精氨酸、4-胍基-1-丁醇、4-胍基-丁酸、水苏糖。本品具有对子宫呈兴奋作用,抗血小板聚集、凝聚作用,改善冠脉循环和保护心脏作用,降低血压等作用。
苍术:味辛、苦,性温;入脾、胃、肝经。本品具有燥湿健脾,祛风散寒,明目等功效。常用治脘腹胀满,泄泻水肿,脚气痿躄,风湿痹痛,风寒感冒,夜盲等证;主治湿困脾胃,倦怠嗜卧,胞痞腹胀,食欲不振,哎吐泄泻,痰饮,湿肿,表证夹湿,头身重痛,痹证温性,肢节酸痛重着,痿襞等证。
现代药理学研究证明:本品具有调整胃肠运动功能,抗溃疡、保肝、抑菌、促进骨骼钙化、抗肿瘤、降压、抗缺氧的药理作用。
紫花地丁:本品味苦辛,性寒,无毒;归心、肝经。功效主治:本品具有清热解毒,凉血消肿等作用常用治黄疸、痢疾、乳腺炎、目赤肿痛、咽炎;外敷治跌打损伤、痈肿、毒蛇咬伤等。
现代医学研究:本品全草含甙类、黄酮类、蜡、蜡酸及不饱和酸等的酯类。紫花地丁在试管内有抑制结核杆菌生长的作用。直接镜检法和试管培养法表明: 紫花地丁(醇提物31mg/ml, 水煎剂62mg/ml)对钩端螺旋体有抑制作用。紫花地丁水浸剂(1:4)在试管内对堇色毛癣菌有抑制作用。此外, 认为紫花地丁尚有清热、消肿、消炎等作用。
连翘:本品味苦,性微寒;入心、肝、胆、胃、三焦、大肠六经。功效主治:本品具有清热解毒,消肿散结等功效;常用治痈疽,瘰疬,乳痈,丹毒,风热感冒,温病初起,温热等证。
现代医学研究:本品果实含连翘酚、甾醇化合物、皂甙(无溶血性)及黄酮醇甙类、马苔树脂醇甙等;果皮含齐墩果酸。本品具有抗菌、强心、利尿、镇吐等药理作用,常用连翘治疗急性风热感冒、痈肿疮毒、淋巴结结核、尿路感染等症。
槟榔:本品味苦、辛,性温;归胃,大肠经。功效主治:本品具有驱虫,消积,下气,行水,截疟等功效;常用治虫积,食滞,脘腹胀痛,泻痢后重,脚气,水肿,疟疾等证。
现代医学研究:槟榔含生物碱,缩合鞣质, 脂肪1及槟榔红色素。本品具有驱虫作用,抗病毒、真菌作用,对胆碱受体作用等。
人参:性温,味甘、微苦;入脾、肺二经。功效主治:1、益气救脱:人参大补元气,培固根本,故有挽救虚脱的功效。2、安神定悸:人参补五脏,安精神,定魂魄,止惊悸。3、培补气血:人参补气补血,培本固元。4、纳气平喘:人参气味温和,肺肾两补,有止虚喘之效。5、生津止渴:人参治气津两伤所致的口渴汗多,气短神疲等,如热病后期,气津两伤,或内伤日久,津气受损,皆见此证,重用人参,可收益气生津之效。6、补中益气。7、益肾补元:人参大补元气,添精神,生津液,久病元虚将脱者必用,病后欲救恢复元气者常服,兼治肾气不固的阳萎、遗精、滑精等证,皆赖其滋补强壮之功。8、扶正去邪。
黄芪:味甘,性微温;入肺、脾、肝、肾经。功效主治:黄芪具有益气固表、敛汗固脱、托疮生肌、利水消肿之功效。用于治疗气虚乏力,中气下陷,久泻脱肛,便血崩漏,表虚自汗,痈疽难溃,久溃不敛,血虚萎黄,内热消渴,慢性肾炎,蛋白尿,糖尿病等。
现代医学研究表明:黄芪含皂甙、蔗糖、多糖、多种氨基酸、叶酸及硒、锌、铜等多种微量元素。具有增强机体免疫功能、保肝、利尿、抗衰老、抗应激、降压和较广泛的抗菌作用。能消除实验性肾炎蛋白尿,增强心肌收缩力,调节血糖含量。黄芪不仅能扩张冠状动脉,改善心肌供血,提高免疫功能,而且能够延缓细胞衰老的进程。
另外,与黄芪补气固表功效相关的药理作用有增强机体免疫功能、增强造血功能;改善物质代谢、增强性腺功能、抗应激、延缓衰老等作用;黄芪还具有强心、调节血压、抗病毒性心肌炎、保肝、抗溃疡等作用;黄芪多糖和黄芪皂苷是其主要有效成分。
红花:味辛、性温,入心、肝经。功效主治:本品具有活血通经,散瘀止痛之功效。用于经闭,痛经,恶露不行,癥瘕痞块,跌打损伤,疮疡肿痛等证。
现代医学研究证明:本品含红花甙、新红花甙、红花醌甙、红花多糖、棕榈酸、肉桂酸、月桂酸等。具有降压、扩张血管、抗凝血、抗疲劳、镇痛和镇静等作用。
白花蛇舌草:味微苦、甘,性寒。入胃、大肠、小肠经。本品苦寒清热解毒,甘寒清利湿热,对痈肿、咽痛、蛇伤等有较强的解毒消痈作用。一般用于治疗疮毒、咽喉肿痛、肠痈腹痛、毒蛇咬伤,也用于热淋涩痛、小便不利等证。
现代药理学研究证明:白花蛇草能增强机体的免疫力,抑制肿瘤细胞的生长,对绿脓杆菌、金黄色葡萄球菌、肺炎球菌、痢疾杆菌等致病菌有抑制作用,实乃“清热解毒”之良药。临床上用于治疗胃炎,肝炎,良性甲状腺结节,顽固性外阴湿疹等。
甘草:性平、味甘,入十二经。功效主治:甘草具有补脾益气,清热解毒,祛痰止咳,缓急止痛,调和诸药等功能。常用于脾胃虚弱,倦怠乏力,心悸气短,咳嗽痰多,脘腹,四肢挛急疼痛,痈肿疮毒,缓解药物毒性、烈性。
现代医学研究:甘草含有多种化学成分,主要成分有甘草酸、甘草甙等。具有抗炎、抗病毒,保肝解毒及增强免疫功能等作用。由于甘草酸有糖皮质激素样药理作用而无严重不良反应,临床被广泛用于治疗各种急慢性肝炎、支气管炎和艾滋病,还具有抗癌防癌、干扰素诱生剂及细胞免疫调节剂等功能。甘草酸具有降血脂与抗动脉粥样硬化作用,阻止动脉粥样硬化的形成。
佩兰:本品味辛,性平;归脾、胃、肺三经。功效主治:本品具有解暑化湿,辟秽和中等功效。常用治感受暑湿,寒热头痛,湿润内蕴,脘痞不饥,恶心呕吐,口中甜腻,消洵等证。
现代医学研究:本品主全草含挥发油1.5~2%,油中含:对-聚伞花素乙酸橙花醇酯和5-甲基麝香草醚,前两者对流感病毒有直接抑制作用;叶含香豆精,邻-香豆酸及麝香草氢醌;大麻叶泽兰的叶,花中都含泽兰苦素和一倍半萜内酯,叶中又含泽兰甙。
车前子:本品味甘、淡,性微寒;归肺、肝、肾、膀胱经。功效主治:本品具有清热利尿,渗湿止泻,明目,祛痰等功效。常用治主小便不利,淋浊带下,水肿胀满,暑湿泻痢,目赤障翳,痰热咳喘等证。
现代医学研究:车前种子含月桃叶珊瑚甙,车前粘多糖,消旋-车前子甙,都桷子甙酸,车前子酸,琥珀酸,腺嘌呤,胆碱及10.43% 的脂肪油,β-谷淄醇、β-谷甾醇-3-O-β-D-吡喃葡萄糖甙。本品具有利尿作用,拟胆碱作用,祛痰、镇咳、平喘作用,抗病原微生物作用,对胃肠道功能有调节作用,明显的解痉作用等。
白藓皮:本品味苦、咸,性寒;入脾、胃经。功效主治:本品具有祛风,燥湿,清热,解毒等功效;常用治风热疮毒,疥癣,皮肤痒疹,风湿痹痛,黄疸等证。
现代医学研究:本品根含白鲜碱、白鲜内酯、谷甾醇、黄柏酮酸、胡芦巴碱、胆碱、梣皮酮;尚含菜油甾醇、茵芋碱、γ-崖椒碱、白鲜明碱;地上部分含有补骨脂素和花椒毒素。本品具有抗菌作用,抗心律失常作用,增强肾上腺素的升压作用,解痉作用,抗癌作用,解热作用等。
蛇床子:本品味辛、苦,性温,有小毒;归肾经。功效主治:本品具有解毒杀虫,燥湿,祛风等功效;常用治外阴湿疹,妇人阴痒,滴虫性阴道炎,湿疹疥癣,寒湿带下,湿痹腰痛,肾虚阳痿,宫冷不孕等证。
现代医学研究:本品含蒎烯、异缬草酸龙脑酯、欧芹酚甲醚、二氢欧山芹醇、佛手柑内酯、蛇床子素、异茴芹素等。具有抗滴虫作用,性激素样作用,平喘作用,抗真菌作用,抗心律失常作用,局麻作用,抗诱变作用,杀虫作用等。
苦参:本品味苦,性寒;归肝,肾,大肠,小肠,膀胱,心经。功效主治:本品具有清热燥湿,祛风杀虫等功效;常用治湿热泻痢,肠风便血,黄疸,小便不利,水肿,带下,阴痒,疥癣,麻风,皮肤瘙痒,湿毒疮疡等证;外治外治滴虫性阴道炎。
现代医学研究:本品主要含生物碱,多种黄酮类化合物;具有美容护肤作用,抗菌作用,抗肿瘤作用,升白作用,抗炎作用,抗心律不齐作用;此外,苦参有明显的利尿作用;苦参生物碱尚有安定、平喘、免疫抑制作用。
芒硝:本品味苦、咸,性寒;归胃经,肺经,脾经,肾经,小肠经,三焦经,大肠经。功效主治:本品具有泻热通便,润燥软坚,清火消肿等功效;常用治实热便秘,大便燥结,积滞腹痛,肠痈肿痛;外治乳痈,痔疮肿痛。
现代医学研究:本品主要成分为十水合硫酸钠Na2SO4·10H2O;具有泻下作用,减轻阑尾炎症作用,引起肠道神经反射作用,消肿止痛作用,利尿作用等。
本发明中药组合物组方科学合理,整方配伍君臣佐使齐全、药力精专、应用灵活,具有较明显的中医特色。本发明组方以山药、野菊花、红花、人参、黄芪、甘草、益母草和酒蒸淫阳藿为君,以煅阴起石、煅阳起石、槟榔、川椒、蛇床子、佩兰、车前子、土茯苓和苍术为臣,以二花、白花蛇舌草、紫花地丁、黄柏、白藓皮、蒲公英、连翘和苦参为佐,以酒为使。以此达到吸附阴道内外残秽细菌(本发明栓剂受湿崩解使其药物发挥效力,改善微循环)、修复阴道损伤粘膜及供给营养、维护阴道内正常菌群平衡状态、保持生殖器官内外清爽干燥、使生殖系统治愈后复发率大幅度降低的目的。本发明结合传统中医学理论,应用扶正祛邪,解毒除湿等方法,开发了本发明治疗生殖性疾病的药物,从而解决了大部分患者治疗困难的问题。利用本发明药物治疗生殖性疾病,不需要吃药、打针,就能够达到标本兼治的目的,使患有生殖性疾病的患者摆脱阴影,正常生活工作。
本发明的积极有益效果:
1、本发明治疗生殖性疾病的药物不仅对妇科生殖性疾病具有显著疗效,而且对男性生殖性疾病也有显著疗效。本发明对生殖性疾病具有有效防止男、女生殖性疾病而诱发的疾病(如盆腔炎、阴囊炎、前列腺炎等)。
2、本发明药物根据中医药性理,采用纯天然原料药、遵古炮制,并采用现代工艺流程,精炼制备而成。本发明药物是一种绿色环保药物。
3、本发明中药组合物组方科学合理,整方配伍君臣佐使齐全、药力精专、应用灵活,具有较明显的中医特色。本发明组方以山药、野菊花、红花、人参、黄芪、甘草、益母草和酒蒸淫阳藿为君,以煅阴起石、煅阳起石、槟榔、川椒、蛇床子、佩兰、车前子、土茯苓和苍术为臣,以二花、白花蛇舌草、紫花地丁、黄柏、白藓皮、蒲公英、连翘和苦参为佐,以酒为使。以此达到吸附阴道内外残秽细菌(本发明栓剂受湿崩解使其药物发挥效力,改善微循环)、修复阴道损伤粘膜及供给营养、维护阴道内正常菌群平衡状态、保持生殖器官内外清爽干燥、使生殖系统治愈后复发率大幅度降低的目的。本发明结合传统中医学理论,应用扶正祛邪,解毒除湿等方法,开发了本发明治疗生殖性疾病的药物,从而解决了大部分患者治疗困难的问题。利用本发明药物治疗生殖性疾病,不需要吃药、打针,就能够达到标本兼治的目的,使患有生殖性疾病的患者摆脱阴影,正常生活工作。
4、利用本发明药物治疗生殖性疾病治愈率较高,有效率达98%,治愈率达90%以上,治愈后由原来传统方法复发率80%降低到20%以下。因此,利用本发明药物治疗生殖性疾病,具有显著疗效。
本发明治疗生殖性疾病药物的临床资料:
临床中针对各类妇科生殖性疾病240例患者,均属女性,年龄在20~55岁之间,平均年龄30岁,有效率98%,治愈率90%以上,复发率仅为7%(一年随访),治疗结果表明:本发明药物不仅对生殖性疾病治疗效果显著,使用方便,无毒副作用,更关键的是复发率较低。
利用本发明药物治疗的240例生殖性疾病患者中,200例患者在使用本发明药物栓剂3天后异味解除,分泌物明显好转;240例患者中80例患者有滴虫性阴道炎,70例患者有霉菌性阴道炎,50例患有细菌性阴道炎,其他阴道炎40例。在240例患者中一般3天开始见效,5-7天能得到控制或治愈,7-14天可加强巩固,240例患者经过本发明药物治疗,痊愈217例,好转18例,无效5例。根据患者的年龄,饮食营养,生活区域,平素身体健康状况以及疾病的轻重程度酌情使用本发明药物。
治疗方法:采用本发明药物栓剂治疗各种妇科生殖性疾病,栓剂的药物配方和制备方法详见上述本发明治疗生殖性疾病药物的配方和制备方法;患者每天晚上睡前使用一次本发明栓剂,本发明药物使用方法基于外用,每日晚临睡前用本发明栓剂药物放入阴道内,栓剂中留一细线把外端固定在大腿内侧,第二天早晨清理局部,并把取出的栓剂处理掉以免二次污染,一个疗程5-7天,重症患者可巩固一个疗程并结合男女同治。
采用男女同治时,将本发明药物处理后装入袋中,将装入药物的袋放入特制内裤中,7天更换一次,如果受到污染及时更换,经常保持生殖处清爽干燥。采用本发明药物治疗期间,慎食生冷辛辣食品,保持清爽干燥,内裤若被尿液及分泌物污染及时更换,保证卫生。
疗效标准:按中医妇科学、性病学有关标准评定:
痊愈:临床症状全部消失,无甚不适,正常夫妻生活与工作;
好转:临床症状有所改善,轻度不适,影响夫妻生活,可正常工作;
无效:临床症状无改善,不能正常工作与夫妻生活。
治疗结果:240例患者经过本发明药物治疗,痊愈217例、好转18例、无效5例,总有效率高达98%。
典型病例:
1、谢某,女,43岁,宝丰县商酒务镇人,该患者经常感到外阴部痒痛,分泌物呈脓性,并有臭味,此状况大概患有3年,从2008年开始。经医院检查确诊为“滴虫性阴道炎”,经过吃药、打针、外用药治疗后,很快就又复发了,一年复发多次,经过长期治疗,总是不能根除。因此,给患者生活和工作带来很大影响。2011年2月经人介绍来我处就诊,采用本发明药物栓剂进行治疗(本发明药物栓剂的药物配方详见实施例1,其制备方法详见技术方案中描述的制备方法),治疗三周治愈,治愈后并遵医嘱预防一年未见复发。
2、陈某,女,25岁,平顶山市宝丰县大营镇人,于2009年的2月患者经常外阴瘙痒、灼痛、白带增多,有时白带呈白色稠厚豆渣样,严重时坐立不安,非常痛苦。经医院检查确诊为“念珠菌性阴道炎”。经过长期吃药、打针、外洗,治好后又反复复发。2010年3月经人介绍来我处就诊,采用本发明药物栓剂进行治疗(本发明药物栓剂的药物配方详见实施例1,其制备方法详见技术方案中描述的制备方法),治疗两周治愈,治愈后并遵医嘱预防一年未见复发。
3、杨某,女,60岁,平顶山市宝丰县南关人,2006年患者经常阴道分泌物增多,呈黄水样或呈血脓性白带,外阴瘙痒或灼痛。经医院确诊为“老年性阴道炎”。经过口服药物、外洗等措施治疗,治疗效果不佳,不能根除,时轻时重。2011年2月经人介绍来我处就诊,采用本发明药物栓剂进行治疗(本发明药物栓剂的药物配方详见实施例3,其制备方法详见技术方案中描述的制备方法),治疗40余天治愈,治愈后并遵医嘱一年未见复发。
4、朱某,男,45岁,平顶山市人,该患者有慢性前列腺炎数年,经常尿急、尿频、尿不净、阴囊潮湿,并且阳瘘、早泄。经过多方治疗均未见好转。2010年7月经人介绍来我处就诊,试着采用本发明药物进行治疗(本发明药物栓剂的药物配方详见实施例2,其制备方法详见技术方案中描述的制备方法),经本发明药物治疗十天后,阴囊不再潮湿并无异味,继续治疗1个月后,尿急、尿频、尿不净明显改善;阳瘘、早泄也有很大好转;治疗3个月后,患者感觉心情舒畅,并继续治疗了一段时间进行防治。
5、王某某,女,38岁,宝丰县大营镇人,患者于2008年开始出现外阴痒痛,白带增多,呈脓性,有时呈血性白带,伴有腰酸腹痛,下腹部重坠感,并有臭味。经医院诊断为“滴虫性阴道炎,宫颈糜烂”等。经过吃药打针症状基本改善,但未彻底治疗反复发作,使工作和生活受到极大影响。于2010年4月来我院治疗,采用本发明药物进行治疗(本发明药物栓剂的药物配方详见实施例1,其制备方法详见技术方案中描述的制备方法),治疗三周治愈,并遵医嘱继续预防,一年后随访无复发。
6 仝某,女,42岁,平顶山市光明路,患者于2005年开始经常感到外阴痒痛,白带增多,呈血色稠厚豆渣样,严重时晚上无法入睡,无法正常工作,非常难受,经医院诊断为“念珠菌感染,滴虫性阴道炎”,经过2年来反复吃药,输液、外洗、外用药治疗,反反复复无法治愈。与2007年2月来我院治疗,采用本发明药物进行治疗(本发明药物栓剂的药物配方详见实施例2,其制备方法详见技术方案中描述的制备方法),治疗18天治愈,患者感觉无甚不适,并遵医嘱预防,现未见复发。
7、程某某,男,45岁,宝丰县杨庄镇人,患者于2000年开始患有前列腺炎(经医院诊断),经过各种方法及多处医院治疗,均时轻时重,未见明显效果。近一年来病情加重,尿急、尿频、尿不净伴有疼痛,阴囊潮湿,严重时内裤经常被污湿,走到哪里都有一种难闻的怪味,无法工作及过正常夫妻生活。与2006年7月来我院就诊,采用本发明药物进行治疗(本发明药物栓剂的药物配方详见实施例3,其制备方法详见技术方案中描述的制备方法),治疗十天后阴囊潮湿明显减轻,并无异味,继续治疗一个月后,尿急、尿不净明显改善无疼痛,已能过夫妻生活。三个月后患者感觉好像和以前一样,现已正常生活和工作,并遵医嘱继续预防,一年后随访一切正常。
四、具体实施方式:
以下结合实施例进一步阐述本发明,但并不限制本发明的内容。
实施例1:
本发明治疗生殖性疾病的化毒和菌中药组合物,以重量份表示,其原料药组成为:山药40份,野菊花40份,煅阴起石40份,煅阳起石40份,淫阳霍30份,二花30份,黄柏30份,土茯苓20份,川椒20份,蒲公英20份,益母草20份,苍术20份,紫花地丁30份,连翘30份,槟榔30份,人参40份,黄芪30份,红花15份,白花蛇舌草30份,甘草15份,佩兰15份,车前子20份,白藓皮30份,蛇床子30份,苦参30份和芒硝70份。
实施例2:与实施例1基本相同,不同之处在于:
本发明治疗生殖性疾病的化毒和菌中药组合物,以重量份表示,其原料药组成为:山药39份,野菊花39份,煅阴起石39份,煅阳起石39份,淫阳霍29份,二花29份,黄柏29份,土茯苓19份,川椒19份,蒲公英19份,益母草19份,苍术19份,紫花地丁29份,连翘29份,槟榔29份,人参39份,黄芪29份,红花14份,白花蛇舌草29份,甘草14份,佩兰14份,车前子19份,白藓皮29份,蛇床子29份,苦参29份和芒硝69份。
实施例3:与实施例1基本相同,不同之处在于:
本发明治疗生殖性疾病的化毒和菌中药组合物,以重量份表示,其原料药组成为:山药41份,野菊花41份,煅阴起石41份,煅阳起石41份,淫阳霍31份,二花31份,黄柏31份,土茯苓21份,川椒21份,蒲公英21份,益母草21份,苍术21份,紫花地丁31份,连翘31份,槟榔31份,人参41份,黄芪31份,红花16份,白花蛇舌草31份,甘草16份,佩兰16份,车前子21份,白藓皮31份,蛇床子31份,苦参31份和芒硝71份。
实施例4:与实施例1基本相同,不同之处在于:
本发明治疗生殖性疾病的化毒和菌中药组合物,以重量份表示,其原料药组成为:山药38份,野菊花38份,煅阴起石38份,煅阳起石38份,淫阳霍28份,二花28份,黄柏28份,土茯苓18份,川椒18份,蒲公英18份,益母草18份,苍术18份,紫花地丁28份,连翘28份,槟榔28份,人参38份,黄芪28份,红花13份,白花蛇舌草28份,甘草13份,佩兰13份,车前子18份,白藓皮28份,蛇床子28份,苦参28份和芒硝68份。
实施例5:与实施例1基本相同,不同之处在于:
本发明治疗生殖性疾病的化毒和菌中药组合物,以重量份表示,其原料药组成为:山药42份,野菊花42份,煅阴起石42份,煅阳起石42份,淫阳霍32份,二花32份,黄柏32份,土茯苓22份,川椒22份,蒲公英22份,益母草22份,苍术22份,紫花地丁32份,连翘32份,槟榔32份,人参42份,黄芪32份,红花17份,白花蛇舌草32份,甘草17份,佩兰17份,车前子22份,白藓皮32份,蛇床子32份,苦参32份和芒硝72份。
实施例6:与实施例1基本相同,不同之处在于:
本发明治疗生殖性疾病的化毒和菌中药组合物,以重量份表示,其原料药组成为:山药41份,野菊花39份,煅阴起石40份,煅阳起石42份,淫阳霍30份,二花32份,黄柏31份,土茯苓20份,川椒22份,蒲公英21份,益母草22份,苍术21份,紫花地丁30份,连翘32份,槟榔30份,人参42份,黄芪31份,红花14份,白花蛇舌草28份,甘草16份,佩兰13份,车前子18份,白藓皮28份,蛇床子28份,苦参31份和芒硝71份。
实施例7:与实施例1基本相同,不同之处在于:
本发明治疗生殖性疾病的化毒和菌中药组合物,以重量份表示,其原料药组成为:山药39份,野菊花40份,煅阴起石42份,煅阳起石38份,淫阳霍32份,二花28份,黄柏28份,土茯苓22份,川椒19份,蒲公英22份,益母草19份,苍术18份,紫花地丁32份,连翘30份,槟榔28份,人参38份,黄芪28份,红花17份,白花蛇舌草31份,甘草15份,佩兰16份,车前子22份,白藓皮31份,蛇床子32份,苦参29份和芒硝69份。
实施例8:与实施例1基本相同,不同之处在于:
本发明治疗生殖性疾病的化毒和菌中药组合物,以重量份表示,其原料药组成为:山药43份,野菊花45份,煅阴起石36份,煅阳起石37份,淫阳霍27份,二花35份,黄柏33份,土茯苓17份,川椒24份,蒲公英25份,益母草25份,苍术17份,紫花地丁27份,连翘26份,槟榔27份,人参45份,黄芪33份,红花19份,白花蛇舌草26份,甘草20份,佩兰12份,车前子16份,白藓皮26份,蛇床子26份,苦参33份和芒硝73份。
实施例9:与实施例1基本相同,不同之处在于:
本发明治疗生殖性疾病的化毒和菌中药组合物,以重量份表示,其原料药组成为:山药37份,野菊花43份,煅阴起石43份,煅阳起石35份,淫阳霍33份,二花26份,黄柏35份,土茯苓15份,川椒25份,蒲公英23份,益母草22份,苍术23份,紫花地丁33份,连翘34份,槟榔30份,人参39份,黄芪30份,红花10份,白花蛇舌草35份,甘草19份,佩兰20份,车前子23份,白藓皮33份,蛇床子33份,苦参30份和芒硝75份。
实施例10:与实施例1基本相同,不同之处在于:
本发明治疗生殖性疾病的化毒和菌中药组合物,以重量份表示,其原料药组成为:山药45份,野菊花37份,煅阴起石37份,煅阳起石43份,淫阳霍25份,二花33份,黄柏27份,土茯苓25份,川椒17份,蒲公英15份,益母草17份,苍术15份,紫花地丁25份,连翘35份,槟榔25份,人参35份,黄芪27份,红花20份,白花蛇舌草336份,甘草12份,佩兰19份,车前子15份,白藓皮27份,蛇床子30份,苦参27份和芒硝65份。
实施例11:与实施例1基本相同,不同之处在于:
本发明治疗生殖性疾病的化毒和菌中药组合物,以重量份表示,其原料药组成为:山药35份,野菊花35份,煅阴起石40份,煅阳起石40份,淫阳霍30份,二花28份,黄柏25份,土茯苓20份,川椒15份,蒲公英17份,益母草20份,苍术25份,紫花地丁27份,连翘27份,槟榔35份,人参37份,黄芪35份,红花17份,白花蛇舌草30份,甘草10份,佩兰10份,车前子19份,白藓皮25份,蛇床子25份,苦参25份和芒硝67份。
实施例12:与实施例1基本相同,不同之处在于:
本发明治疗生殖性疾病的化毒和菌中药组合物,以重量份表示,其原料药组成为:山药40份,野菊花40份,煅阴起石39份,煅阳起石39份,淫阳霍29份,二花30份,黄柏30份,土茯苓19份,川椒21份,蒲公英20份,益母草18份,苍术19份,紫花地丁29份,连翘30份,槟榔31份,人参42份,黄芪29份,红花19份,白花蛇舌草29份,甘草18份,佩兰16份,车前子21份,白藓皮30份,蛇床子27份,苦参32份和芒硝70份。
上述实施例1-12本发明治疗生殖性疾病的化毒和菌中药组合物的制备方法:
a、首先按照上述实施例治疗生殖性疾病的化毒和菌中药组合物的配比比例称取各种原料药;
b、将步骤a称取的原料药淫阳藿先酒蒸30分钟,然后与原料药山药、野菊花、红花、人参、黄芪、甘草和益母草加入砂锅内,并加入清水,清水的加入量为所加入的原料药总重量的3~5倍,加入清水后进行加热煎煮25~35分钟,过滤后接着煮25~35分钟,煮后再进行过滤得到第一次上清液;按照同样的煎煮方法进行三次过滤处理,得到三次上清液,将三次得到的上清液混合均匀;接着将混合均匀的上清液熬制成膏状得到膏状药物,将膏状药物进行烘干粉碎,得到菌和膏粉;
c、将步骤a称取的原料药二花、白花蛇舌草、紫花地丁、黄柏、白藓皮、蒲公英、连翘和苦参放入砂锅,然后加入水浸泡50~70分钟,水的加入量是所加入的原料药总重量的5~8倍,浸泡后进行加热熬制,煮沸后熬制20~30分钟,熬制后进行过滤得到第一次滤液,按照同样的熬制方法连续熬制2~3次,将所得2~3次的滤液进行混合得到混合药液,将混合药液放入不带釉的瓦罐内,并将称取的原料药芒硝加入混合药液中,封严罐口,悬挂在阴凉通风处,待瓦罐外析出白色结晶物时进行收集,至无结晶物析出为止,将析出的白色结晶物全部收集,得到霜体药物即称之为毒清霜,储备待用;
d、将步骤a称取的原料药煅阴起石、煅阳起石、槟榔、川椒、蛇床子、佩兰、车前子、土茯苓和苍术分别粉碎,粉碎后混合均匀,最后加入纯粮酒焖制22~24小时,所加入的原料药的总重量与纯粮酒二者之间的重量比为1:1,焖制后得到稠糊状药物,取出按照栓剂常规方法制备成直径为1cm、长1.5cm的空心栓剂,将空心栓剂用火煅透存性备用;
e、将步骤b得到的菌和膏粉放入步骤d得到的空心栓剂内,空心栓剂外面用吸附性较强的细薄绢布包好,将步骤c得到的霜体药物即毒清霜置于细薄绢布之间,最后装入真空袋内密封,高压灭菌,灭菌后备用。
Claims (1)
1. 一种治疗生殖性疾病的化毒和菌中药组合物,其特征在于:以重量份表示,所述治疗生殖性疾病的化毒和菌中药组合物由原料药山药35~45份,野菊花35~45份,煅阴起石35~45份,煅阳起石35~45份,淫羊藿25~35份,金银花25~35份,黄柏25~35份,土茯苓15~25份,川椒15~25份,蒲公英15~25份,益母草15~25份,苍术15~25份,紫花地丁25~35份,连翘25~35份,槟榔25~35份,人参35~45份,黄芪25~35份,红花10~20份,白花蛇舌草25~35份,甘草10~20份,佩兰10~20份,车前子15~25份,白鲜皮25~35份,蛇床子25~35份,苦参25~35份和芒硝65~75份组成。
2.根据权利要求1所述的治疗生殖性疾病的化毒和菌中药组合物,其特征在于:所述治疗生殖性疾病的化毒和菌中药组合物由原料药山药38~42份,野菊花38~42份,煅阴起石38~42份,煅阳起石38~42份,淫羊藿28~32份,金银花28~32份,黄柏28~32份,土茯苓18~22份,川椒18~22份,蒲公英18~22份,益母草18~22份,苍术18~22份,紫花地丁28~32份,连翘28~32份,槟榔28~32份,人参38~42份,黄芪28~32份,红花13~17份,白花蛇舌草28~32份,甘草13~17份,佩兰13~17份,车前子18~22份,白鲜皮28~32份,蛇床子28~32份,苦参28~32份和芒硝68~72份组成。
3.根据权利要求1所述的治疗生殖性疾病的化毒和菌中药组合物,其特征在于:所述治疗生殖性疾病的化毒和菌中药组合物由原料药山药40份,野菊花40份,煅阴起石40份,煅阳起石40份,淫羊霍30份,金银花30份,黄柏30份,土茯苓20份,川椒20份,蒲公英20份,益母草20份,苍术20份,紫花地丁30份,连翘30份,槟榔30份,人参40份,黄芪30份,红花15份,白花蛇舌草30份,甘草15份,佩兰15份,车前子20份,白鲜皮30份,蛇床子30份,苦参30份和芒硝70份组成。
4.一种治疗生殖性疾病的化毒和菌中药组合物的制备方法,其特征在于,所述制备方法包括以下步骤:
a、首先按照权利要求1~3任一项所述治疗生殖性疾病的化毒和菌中药组合物的配比比例称取各种原料药;
b、将步骤a称取的原料药淫羊藿先酒蒸30分钟,然后与原料药山药、野菊花、红花、人参、黄芪、甘草和益母草加入砂锅内,并加入清水,清水的加入量为所加入的原料药总重量的3~5倍,加入清水后进行加热煎煮25~35分钟,过滤后接着煮25~35分钟,煮后再进行过滤得到第一次上清液;按照同样的煎煮方法进行三次过滤处理,得到三次上清液,将三次得到的上清液混合均匀;接着将混合均匀的上清液熬制成膏状得到膏状药物,将膏状药物进行烘干粉碎,得到菌和膏粉;
c、将步骤a称取的原料药金银花、白花蛇舌草、紫花地丁、黄柏、白鲜皮、蒲公英、连翘和苦参放入砂锅,然后加入水浸泡50~70分钟,水的加入量是所加入的原料药总重量的5~8倍,浸泡后进行加热熬制,煮沸后熬制20~30分钟,熬制后进行过滤得到第一次滤液,按照同样的熬制方法连续熬制2~3次,将所得2~3次的滤液进行混合得到混合药液,将混合药液放入不带釉的瓦罐内,并将称取的原料药芒硝加入混合药液中,封严罐口,悬挂在阴凉通风处,待瓦罐外析出白色结晶物时进行收集,至无结晶物析出为止,将析出的白色结晶物全部收集,得到霜体药物即称之为毒清霜,储备待用;
d、将步骤a称取的原料药煅阴起石、煅阳起石、槟榔、川椒、蛇床子、佩兰、车前子、土茯苓和苍术分别粉碎,粉碎后混合均匀,最后加入纯粮酒焖制22~24小时,所加入的原料药的总重量与纯粮酒二者之间的重量比为1:1,焖制后得到稠糊状药物,取出按照栓剂常规方法制备成直径为1cm、长1.5cm的空心栓剂,将空心栓剂用火煅透存性备用;
e、将步骤b得到的菌和膏粉放入步骤d得到的空心栓剂内,空心栓剂外面用吸附性较强的细薄绢布包好,将步骤c得到的霜体药物即毒清霜置于细薄绢布之间,最后装入真空袋内密封,高压灭菌,灭菌后备用。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210251606.3A CN102764394B (zh) | 2012-07-20 | 2012-07-20 | 治疗生殖性疾病的化毒和菌中药组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210251606.3A CN102764394B (zh) | 2012-07-20 | 2012-07-20 | 治疗生殖性疾病的化毒和菌中药组合物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102764394A CN102764394A (zh) | 2012-11-07 |
CN102764394B true CN102764394B (zh) | 2014-03-26 |
Family
ID=47092121
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210251606.3A Expired - Fee Related CN102764394B (zh) | 2012-07-20 | 2012-07-20 | 治疗生殖性疾病的化毒和菌中药组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102764394B (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106177204A (zh) * | 2016-08-03 | 2016-12-07 | 韦爱小 | 一种治疗急性盆腔炎的中药组合物 |
CN109730962A (zh) * | 2018-12-25 | 2019-05-10 | 深州市救坤堂中医药科技有限责任公司 | 一种治疗妇科炎症的坐药及其制备方法 |
CN117223809B (zh) * | 2023-11-10 | 2024-02-02 | 山东向日葵生物工程有限公司 | 一种消炎利尿的发酵乳杆菌sf-l35发酵药用饮品及应用 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101810816A (zh) * | 2010-05-25 | 2010-08-25 | 泰一和浦(北京)中医药研究院有限公司 | 一种治疗带下的中药组合物及其制备方法 |
-
2012
- 2012-07-20 CN CN201210251606.3A patent/CN102764394B/zh not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101810816A (zh) * | 2010-05-25 | 2010-08-25 | 泰一和浦(北京)中医药研究院有限公司 | 一种治疗带下的中药组合物及其制备方法 |
Non-Patent Citations (2)
Title |
---|
中药治疗慢性前列腺炎概况;孙建明;《山西中医》;19970630;第13卷(第03期);47-49 * |
孙建明.中药治疗慢性前列腺炎概况.《山西中医》.1997,第13卷(第03期), |
Also Published As
Publication number | Publication date |
---|---|
CN102764394A (zh) | 2012-11-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102772737B (zh) | 用于治疗肝硬化纤维化的中药组合物及其制备方法 | |
CN102178814B (zh) | 一种治疗滴虫性阴道炎的中药组合物及其制备方法 | |
CN101249257A (zh) | 一种治疗水肿的中药制剂 | |
CN105055950A (zh) | 一种治疗复发性口腔溃疡的中药制剂及其制备方法 | |
CN102805843B (zh) | 一种治疗胃痛的药物及其制备方法 | |
CN104524287A (zh) | 一种治疗过敏性紫癜的中药组合物及其制备方法 | |
CN102512616B (zh) | 一种中草药祛痘组合物 | |
CN102764394B (zh) | 治疗生殖性疾病的化毒和菌中药组合物及其制备方法 | |
CN103520530B (zh) | 一种治疗丹毒的药物及其制备方法 | |
CN105497840A (zh) | 祛湿除热消炎汤 | |
CN105106885A (zh) | 降逆止痛养胃汤 | |
CN106540167A (zh) | 一种减肥中药 | |
CN103505530B (zh) | 用于治疗变异性麻疹的中药组合物 | |
CN104873828A (zh) | 一种治疗放射性皮肤损伤的中药制剂及其制备方法 | |
CN101129763A (zh) | 治疗产后缺乳的一种中成药 | |
CN102727738A (zh) | 用于治疗慢性阻塞性肺疾病的中药组合物及其制备方法 | |
CN105435131A (zh) | 一种治疗慢性心衰的中药组合物及其制备方法 | |
CN105362587A (zh) | 一种改善内分泌失调导致的不孕的组合物及其制备方法 | |
CN104971216A (zh) | 治疗便秘的代茶饮及其制法 | |
CN104940672A (zh) | 一种治疗胆囊结石的中药及制备方法 | |
CN101129932A (zh) | 一种治疗乳房积乳囊肿的中药制剂 | |
CN104398927A (zh) | 治疗膝关节滑膜炎的中药制剂 | |
CN103977279A (zh) | 一种治疗母猪子宫炎的中药添加剂及其制备方法 | |
CN101085154A (zh) | 治疗带下病的中药组合及其制备方法 | |
CN101129938A (zh) | 治疗输卵管炎的一种中药制剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140326 |
|
CF01 | Termination of patent right due to non-payment of annual fee |